Effects of benfluorex on serum triacylglycerols and insulin sensitivity in the corpulent rat

Canadian Journal of Physiology and Pharmacology

Volumn 74, Issue 8, 1996, Pages 879-886

  Russell, J C ^a,c   Graham, S E ^a   Dolphin, P J ^b   Brindley, D N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c ALBERTA ENVIRONMENT AND PARKS   (Canada)

Author keywords

Benfluorex; Insulin resistance; JCR:LA cp rat; Obesity; Type 2 (non insulin dependent) diabetes

Indexed keywords

BENFLUOREX; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; DIABETES MELLITUS; FEMALE; INSULIN SENSITIVITY; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT;

ANIMALS; ANTILIPEMIC AGENTS; BODY WEIGHT; DISEASE MODELS, ANIMAL; EATING; FEMALE; FENFLURAMINE; INSULIN; MALE; OBESITY; RATS; RATS, INBRED STRAINS; SENSITIVITY AND SPECIFICITY; TRIGLYCERIDES;

EID: 0030460371     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/cjpp-74-8-879     Document Type: Article

References (49)

1. Amy, R.M., Dolphin, P.J., Pederson, R.A., and Russell, J.C. 1988. Atherogenesis in two strains of obese rats. The fatty Zucker and LA/N-corpulent. Atherosclerosis, 69: 199-209.
2. Arnaud, O., and Nathan, C. 1990. Antiobesity and lipid-lowering agents with antidiabetic activity. In New anti-diabetic drugs. Edited by C.J. Bailey and R.P. Flatt. Smith-Gordon, London. pp. 133-142.
3. Bailey, C.J., Page, T., Day, C., and Thorburn, C.C. 1992. Acute effects of benfluorex on glucose metabolism. Biochem. Pharmacol. 44: 379-382.
4. Bianchi, R., Bongars, V., Bravenboer, B., and Erkelens, D.W. 1993. Effects of benfluorex on insulin resistance and lipid metabolism in obese type II diabetic patients. Diabetes Care, 16: 557-559.
5. Blondel, O., Serradas, P., Bailbe, D., and Portha, B. 1990. Insulin resistance in rats with non-insulin dependent diabetes induced by neonatal streptozotocin: evidence for reversal following benfluorex treatment. Diabetologia, 33(Suppl. 1): A229.
6. Brindley, D.N. 1983. Phenylethylamines and their effects on the synthesis of fatty acids, triacylglycerols and phospholipids. In Biochemical pharmacology of obesity. Edited by P.B. Curtis-Prior. Elsevier Science Publishers, Amsterdam. pp. 285-308.
7. Brindley, D.N. 1992. Mode d'action du benfluorex: données récentes. Presse Med. 28: 1330-1335.
8. Brindley, D.N. 1993a. Mechanisms for the effects of benfluorex in the obese-diabetic-dyslipidemic syndrome. Diabetes Metab. Rev. 9(Suppl. 1): 51S-56S.
9. Brindley, D.N. 1993b. Neuroendocrine regulation and obesity. Int. J. Obes. 16: 575-579.
10. Brindley, D.N., and Rolland, Y. 1989. Possible connections between stress, diabetes, obesity, hypertension and altered lipoprotein metabolism that may result in atherosclerosis. Clin. Sci. 77: 453-461.
11. Brindley, D.N., and Salter, A.M. 1991. Hormonal regulation of the hepatic low density lipoprotein receptor: relationship with the secretion of very low density lipoproteins. Prog. Lipid Res. 30: 349-360.
12. Brindley, D.N., Akester, H., Derrick, G.P., Irvine, G.O., Patmore, R.D., Spencer, H., Yule-Smith, A., Finnerty, C., Saxton, J., MacDonald, I.A., and Rolland, Y. 1988. Effects of chronic administration of benfluorex to rats on the metabolism of corticosterone, glucose, triacylglycerols, glycerol and fatty acid. Biochem. Pharmacol. 37: 695-705.
13. Brindley, D.N., Hales, P., Al-Sieni, A.I.I., and Russell, J.C. 1991. Decreased serum lipids, serum insulin and triacylglycerol synthesis in adipose tissue of JCR:LA-corpulent rats treated with benfluorex. Biochim. Biophys. Acta, 1085: 119-125.
14. Brindley, D.N., McCann, B.S., Niawa, R., Storey, C.M., and Suarez, E. 1993. Stress and lipoprotein metabolism: modulators and mechanisms. Metab. Clin. Exp. 42(Suppl. 1): 3-15.
15. Chan, C.B., Pederson, R.A., Buchan, A.M.J., Tubesing, K.B., and Brown, J.C. 1984. Gastric inhibitory polypeptide (GIP) and insulin release in the obese Zucker rat. Diabetes, 33: 536-542.
16. De Lean, A., Munson, P.J., and Rodbard, D. 1978. Simultaneous analysis of families of sigmoid curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol. 235: E97-E102.
17. De Lean, A., Munson, P.J., Guardobasso, V., and Rodbard, D. 1988. A user's guide to ALLFIT. National Institutes of Health, Bethesda, Md.
18. Després, J.-P. 1991. Obesity and lipid metabolism: relevance of body fat distribution. Curr. Opin. Lipidol. 2: 5-15.
19. Dolphin, P.J., Stewart, B., Amy, R.M., and Russell, J.C. 1987. Serum lipids and lipoproteins in the atherosclerosis prone LA/N-corpulent rat. Biochim. Biophys. Acta, 919: 140-148.
20. Howard, B.V., Schneiderman, N., Faulkner, B., Hoffner, S.M., and Laws, A. 1993. Insulin, health behaviors, and lipid metabolism. Metab. Clin. Exp. 42(Suppl. 1): 25-35.
21. Koletsky, S. 1973. Obese spontaneously hypertensive rats: a model for the study of atherosclerosis. Exp. Mol. Pathol. 19: 53-60.
22. Kraegen, E.W., James, D.E., Bennett, S.P., and Chisholm, D.J. 1983. In vivo insulin sensitivity in the rat determined by euglycemic clamp. Am. J. Physiol. 245: E1-E7.
23. Kuksis, A., Myher, J.J., Geher, K., Hoffman, A.G.D., Breckenridge, W.C., Jones, G.J.L., and Little, J.A. 1978. Comparative determination of plasma cholesterol and triacylglycerol levels by automated gas-liquid chromatographic and autoanalyzer techniques. J. Chromatogr. 146: 393-412.
24. Lacour, F., Espinal, J., Arnaud, O., and Duhault, J. 1993. Improvement of glucose tolerance of insulin resistant rats after chronic or acute administration of benfluorex. Life Sci. 53: 1525-1529.
25. Pasquali, R., Collella, P., Zanbmarini, L., Melchionda, N., and Barbara, L. 1989. Benfluorex action on metabolic control and insulin sensitivity in type 2 non-insulin dependent diabetes. Panminerva Med. 31: 114-118.
26. Pederson, R.A., Campos, R.V., Buchan, A.M.J., Chisholm, C.B., Russell, J.C., and Brown, J.C. 1991. Comparison of the enteroinsular axis in two strains of obese rat, the fatty Zucker and JCR:LA-corpulent. Int. J. Obes. 15: 461-470.
27. Reaven, G.M. 1988. Role of insulin resistance in human disease. Diabetes, 37: 1595-1607.
28. Russell, J.C., and Amy, R.M. 1986a. Early atherosclerotic lesions in a susceptible rat model: the LA/N-corpulent rat. Atherosclerosis, 60: 119-129.
29. Russell, J.C., and Amy, R.M. 1986b. Myocardial and vascular lesions in the LA/N-corpulent rat. Can. J. Physiol. Pharmacol. 64: 1272-1280.
30. Russell, J.C., Ahuja, S.K., Manickavel, V., Rajotte, R.V., and Amy, R.M. 1987. Insulin resistance and impaired glucose tolerance in the atherosclerosis-prone LA/N corpulent rat. Arteriosclerosis, 7: 620-626.
31. Russell, J.C., Amy, R.M., Manickavel, V., and Dolphin, P.J. 1989a. Effects of chronic ethanol consumption in atherosclerosis-prone JCR:LA-corpulent rat. Arteriosclerosis, 9: 122-128.
32. Russell, J.C., Amy, R.M., Manickavel, V., Dolphin, P.J., Epling, W.F., Pierce, D., and Boer, D.P. 1989b. Prevention of myocardial disease in JCR:LA-corpulent rats by running. J. Appl. Physiol. 66: 1649-1655.
33. Russell, J.C., Koeslag, D.G., Amy, R.M., and Dolphin, P.J. 1989c. Plasma lipid secretion and clearance in hyperlipidemic JCR:LA-corpulent rats. Arteriosclerosis, 9: 869-876.
34. Russell, J.C., Koeslag, D.G., Dolphin, P.J., and Amy, R.M. 1990a. Prevention of myocardial lesions in JCR:LA-corpulent rats by nifedipine. Arteriosclerosis, 10: 658-664.
35. Russell, J.C., Koeslag, D.G., Manickavel, V., Amy, R.M., and Dolphin, P.J. 1990b. Effects of advancing age and severe food restriction on pathological processes in the insulin resistant JCR:LA-corpulent rat. Diabetes Res. 15: 53-62.
36. Russell, J.C., Amy, R.M., Michaelis IV, O.E., McCune, S.M., and Abraham, A.A. 1991a. Myocardial disease in the corpulent strains of rats. In Frontiers in diabetes research: lessons from animal diabetes. III. Edited by E. Shafrir. Smith-Gordon, London. pp. 402-407.
37. Russell, J.C., Dolphin, P.J., Hameed, M. Stewart B., Koeslag, D.G., Rose-Kahn, G., and Bar-Tana, J. 1991b. Hypolipidemic effect of β,β′-tetramethylhexadecanedioic acid (MEDICA 16) in hyperlipidemic JCR:LA-corpulent rats. Arterioscler. Thromb. 11: 602-609.
38. Russell, J.C., Graham, S., and Hameed, M. 1994. Abnormal insulin and glucose metabolism in the JCR:LA-corpulent rat. Metab. Clin. Exp. 43: 538-543.
39. Russell, J.C., Graham, S., Stewart, B., and Dolphin, P.J. 1995. Sexual dimorphism in the metabolic response to the calcium channel antagonists, diltiazem and clentiazem, by hyperlipidemic JCR:LA-cp rats. Biochim. Biophys. Acta, 1258: 199-205.
40. Smith, D., Rossetti, L., Ferrannini, E., Johnson, C.M., Cobelli, C., Toffolo, G., Katz, L.D., and DeFronzo, R.A. 1987. In vivo glucose metabolism in the awake rat: tracer and insulin clamp studies. Metab. Clin. Exp. 36: 1167-1174.
41. Steiner, G. 1986. Hypertriglyceridemia and carbohydrate intolerance: interrelations and therapeutic implications. Am. J. Cardiol. 57: 27G-30G.
42. Storlien, L.H., Oakes, N.D., Pan, D.A., Kusunoki, M., Jenkins, A.B., Kraegen, E.W., and Chisholm, D.J. 1993. Three syndromes of insulin resistance in the rat: inducement by diet and amelioration with benfluorex. Diabetes, 42: 457-462.
43. Terrattaz, J., Assimacopoulos-Jeannet, F., and Jeanrenaud, B. 1986. Severe hepatic and peripheral insulin resistance as evidenced by euglycemic clamps in genetically obese fa/fa rats. Endocrinology (Baltimore), 118: 674-678.
44. Uusitupa, M.I.J., Niskanen, L.K., Siitonen, O., Voutilainen, E., and Pyorala, K. 1990. 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin dependent diabetic and non-diabetic subjects. Circulation, 82: 27-36.
45. Vance, J.E., and Russell, J.C. 1990. Hypersecretion of VLDL, but not HDL, by hepatocytes from the JCR:LA-corpulent rat. J. Lipid Res. 31: 1491-1501.
46. Vigili de Kreutzenberg, S., Riccio, A., Dorella, M., Da Tos, V., and Del Prato, S. 1992. Mécanismes de l'action hypoglycémiante du benfluorex. Presse Med. 28: 1340-1343.
47. Wang, C.N., McLeod, R.S., Yao, Z., and Brindley, D.N. 1995. Effects of dexamethasone on the synthesis, degradation, and secretion of apolipoprotein B in cultured rat hepatocytes. Arterioscler. Thromb. Vasc. Biol. 15: 1481-1491.
48. Zucker, L.M., and Antoniades, H.N. 1972. Insulin and obesity in the Zucker genetically obese rat, "fatty." Endocrinology (Baltimore), 90: 1320-1330.
49. Zucker, L.M., and Zucker, T.F. 1961. Fatty: a new mutation in the rat. J. Hered. 52: 275-278.